Ali Abbara
London, United Kingdom
Wed 04 12:15
OC6.2
Oral communications 6: Advances in reproduction and signalling
Kisspeptin-54 safely and effectively triggers oocyte maturation during IVF treatment in women at high risk of developing ovarian hyperstimulation syndrome (OHSS)
London, United Kingdom
Bo Abrahamsen
Tue 03 15:15
OC2.5
Oral Communications 2: Translational pathophysiology and therapeutics
Age at first major osteoporotic fracture in Danes aged 50 and over: influence of diabetes on mean age at fracture and one year mortality
Simak Ali
London, UK
Wed 04 12:00
S11.1
Symposium 11: Epigenetics in endocrine-related cancers
Oestrogen receptors and epigenetics in breast cancer aetiology and outcome
London, UK
Amit Allahabadia
Wed 04 09:15
CMW4.1
Clinical Management Workshop 4: How do I do it? (II)
How do I prep a thyrotoxic patient for urgent surgery?
Professor Richard Anderson
Edinburgh, UK
Tue 03 12:15
MTE3
Meet the Expert 3: Optimising fertility in teenage cancer survivors
Optimising fertility in teenage cancer survivors
Edinburgh, UK
David Anderson
Rome, Italy
Wed 04 12:54
SE1.4
Senior Endocrinologists Session
A crackpot ejection theory about China's unique natural glass
Rome, Italy
Professor Wiebke Arlt
London, UK
Tue 03 18:00
PL6
Plenary Lecture 6: Clinical Endocrinology Trust Lecture
Mining the steroid metabolome in adrenal hormone excess
London, UK
Richard Auchus
Ann Arbor, USA
Tue 03 18:30
PL7
Plenary Lecture 7: Clinical Endocrinology Trust Visiting Professor Lecture
The expanding universe of mineralocorticoids in hypertension
Ann Arbor, USA
Dr John Ayuk
Birmingham
Tue 03 10:30
N1.1
Nurse Session 1: Multiple Endocrine Neoplasia
Overview of MEN
Birmingham
Steve Ball
Manchester, United Kingdom
Tue 03 11:00
CMW2.2
Clinical Management Workshop 2: Management of pituitary disease: beyond the adenoma
How to improve management of craniopharyngioma
Manchester, United Kingdom
Thomas Barber
Wed 04 10:00
CMW4.4
Clinical Management Workshop 4: How do I do it? (II)
How do I manage hirsutism?
Leela Barham
Wed 04
Shire Satellite: Understanding adrenal insufficiency (AI): from disease burden to treatment evaluation
The economics of orphan drugs
Louise Bath
Mon 02 16:00
CMW1.3
Clinical Management Workshop 1: How do I do it? (I)
How do I investigate and manage gynaecomastia?
Paul Beltchetz
Wed 04 12:18
SE1.2
Senior Endocrinologists Session
What is visual art, why is it made, and for whom?
Felix Beuschlein
Zürich, Switzerland
Mon 02 11:00
S2.2
Symposium 2: Zoning in on adrenal tumours
Advances in genetic causes of adrenal Cushing’s
Zürich, Switzerland
John Bevan
Tue 03
Ipsen Satellite: Treatment of pituitary patients: What are the clinical and patients’ needs?
Somatostatin analogue therapy for acromegaly; what matters to patients?
Susan Bird
Mon 02 12:15
FUT1.1
Futures 1: Branching out with endocrinology
Insights into career patterns for graduates of a biological sciences degree
Louise Breen
London
Tue 03 14:15
N2.1
Nurse Session 2: Nurse-led clinics
Development of a nurse-led hyperparathyroidism clinic
London
Dr Antonia Brooke
Exeter, UK
Tue 03
Ipsen Satellite: Treatment of pituitary patients: What are the clinical and patients’ needs?
The experience of acromegaly: patients’ perspectives
Exeter, UK
Morris Brown
Mon 02 10:30
S2.1
Symposium 2: Zoning in on adrenal tumours
Somatic mutations and adrenal remodelling in hyperaldosteronism
Robert Brown
Wed 04 13:00
S11.3
Symposium 11: Epigenetics in endocrine-related cancers
Epigenetic signalling and acquired drug resistance in ovarian cancer
Federica Buonocore
London, UK
Tue 03 16:15
OC3.1
Oral Communications 3: Steroids and adrenal
Molecular diagnosis of patients with adrenal insufficiency using a targeted custom Haloplex next-generation sequencing panel
London, UK
Moray Campbell
Buffalo, USA
Wed 04 12:30
S11.2
Symposium 11: Epigenetics in endocrine-related cancers
Regulation of androgen receptor function in prostate cancer
Buffalo, USA
James Cannon
Tue 03 11:00
SK2.3
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
Making science cool for kids
Anne Cappola
Philadelphia, USA
Tue 03 17:15
S9.3
Symposium 9: The endocrinology of the thin
Ghrelin in frailty
Philadelphia, USA
Dr Paul Carroll
London, UK
Tue 03 11:30
CMW2.3
Clinical Management Workshop 2: Management of pituitary disease: beyond the adenoma
Inflammatory and autoimmune pituitary disease
London, UK
Ben Challis
Wed 04 12:30
OC5.3
Oral communications 5: Thyroid and parathyroid
Use of 11-C-Methionine PET to loacliase parathyroid adenoma/hyperplasia-a single centre experience
Andrew Childs
London, United Kingdom
Mon 02 12:25
FUT1.2
Futures 1: Branching out with endocrinology
From postdoc to P.I. – transition to independence
London, United Kingdom
Vasileios Chortis
Birmingham, United Kingdom
Tue 03 17:00
OC3.4
Oral Communications 3: Steroids and adrenal
Urine steroid metabolomics as a novel diagnostic tool for early detection of recurrence in adrenocortical carcinoma
Birmingham, United Kingdom
Helen Christian
Mon 02 12:15
MTE1
Meet the Expert 1: Cutting edge imaging of whole endocrine organs
Cutting edge imaging of whole endocrine organs
Professor Alexander Comninos
London, UK
Mon 02 18:00
ECP1.2
Early Career Prize Lectures
Clinical: Kisspeptin- A ‘Key Regulator' of Reproductive Physiology, Integrating Limbic Circuits with the Regulation of Reproductive Hormones
London, UK
Becky Conway-Campbell
Tue 03 17:15
OC3.5
Oral Communications 3: Steroids and adrenal
Glucocorticoid pattern-dependent gene regulation in the rat hippocampus
Melanie Davies
Mon 02 16:30
S5.3
Symposium 5: Premature ovarian insufficiency
Management of oestrogen replacement and potential for fertility in young women with premature ovarian insufficiency
Prof. Colin Dayan
Cardiff, Wales
Mon 02 19:00
D1.1
Debate: This house believes that patients with hypothyroidism should be offered combination treatment with T3 and T4 if they do not respond to Levothyroxine
FOR
Cardiff, Wales
Tue 03 10:30
S6.1
Symposium 6: Clinical implications of thyroid genomics
Thyroid genomics - relevance to thyroid hormone therapy
Cardiff, Wales
Waljit Dhillo
London, UK
Mon 02 12:35
FUT2.3
Futures 2: Overcoming the consultancy hurdle
Research pathways in endocrinology – a UK and global perspective
London, UK
Mon 02 14:45
PL2
Plenary Lecture 2: Society for Endocrinology Medal Lecture
Kisspeptin - a vital trigger of puberty with therapeutic potential
London, UK
Frank Duca
Toronto, Canada
Wed 04 09:45
S10.2
Symposium 10: Blood and guts: how the intestine transduces nutritional cues to endocrine signals
Gut lipid sensing and energy homeostasis
Toronto, Canada
Jane Evanson
London
Tue 03 10:30
CMW2.1
Clinical Management Workshop 2: Management of pituitary disease: beyond the adenoma
Weird and wonderful pituitary imaging
London
Chona Feliciano
Tue 03 14:45
N2.2
Nurse Session 2: Nurse-led clinics
Running a general endocrine nurse-led clinic
Thomas Flint
Tue 03 16:45
S9.2
Symposium 9: The endocrinology of the thin
Paradoxical metabolism neutralizes immunity in cachexia
Gary Frost
Wed 04 10:15
S10.3
Symposium 10: Blood and guts: how the intestine transduces nutritional cues to endocrine signals
Short chain fatty acids in the regulation of energy homeostasis
Alastair Garfield
Wed 04 14:45
MTE7
Meet the Expert 7: Designer Receptors Exclusively Activated by Designer Drugs (DREADD) - Novel pharmacological handles on the endocrine system
Designer receptors Exclusively Activated by Designer Drugs (DREADD) - Novel pharmacological handles on the endocrine system
Annalisa Gastaldello
Tue 03 16:45
OC4.3
Oral Communications 4: Diabetes and cardiometabolic complications
5α-Tetrahydrocorticosterone exhibits topical anti-inflammatory action with limited adverse effects on angiogenesis
Laura Gathercole
Tue 03 17:30
OC3.6
Oral Communications 3: Steroids and adrenal
Female 5β-reductase knockout mice are protected from diet induced obesity, insulin resistance and glucose intolerance
Jyothis George
Mon 02 15:30
OC1.1
Oral Communications 1:Early Career Prize Session
A novel pharmacological approach to target LH and testosterone hypersecretion in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled multi-centre randomised clinical trial of the neurokinin B receptor antagonist AZD4901
Natalie German
Boston, USA
Mon 02 10:30
S3.1
Symposium 3: Fanning the flames of mitochondrial function
Novel regulation of fat metabolism in cancer
Boston, USA
Jacqueline Gilbert
Mon 02 16:45
CMW1.6
Clinical Management Workshop 1: How do I do it? (I)
How do I manage suspected non compliance for thyroxine replacement?
Anne-Paule Gimenez-Roqueplo
Paris, France
Mon 02 11:30
S2.3
Symposium 2: Zoning in on adrenal tumours
The new genetics of phaeochromocytoma
Paris, France
Thomas Giordano
Ann Arbor, USA
Tue 03 11:30
S6.3
Symposium 6: Clinical implications of thyroid genomics
TCGA genomic characterisation of papillary thyroid carcinoma
Ann Arbor, USA
Professor Neil Gittoes
Birmingham, United Kingdom
Mon 02 15:45
CMW1.2
Clinical Management Workshop 1: How do I do it? (I)
How do I treat osteoporosis after bisphosphonates?
Birmingham, United Kingdom
Dr. Caroline Gorvin
Birmingham, UK
Wed 04 12:45
OC6.4
Oral communications 6: Advances in reproduction and signalling
Calcium-sensing receptor internalisation is impaired in cells expressing FHH3-associated AP2σ mutations
Birmingham, UK
Gillian Gray
Wed 04 12:00
S12.1
Symposium 12: Corticosteroids - getting to the heart of the matter
Glucocorticoids and the control of cardiac function
Mrs Jo Grey
Southborough, UK
Tue 03 10:45
SK2.2
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
The battles of writing a lay summary
Southborough, UK
Ashley Grossman
Wed 04 14:45
MTE9
Meet the Expert 9: Endocrine and non-endocrine aspects of hypothalamic syndromes
Endocrine and non-endocrine aspects of hypothalamic syndromes
Mark Gurnell
Cambridge, United Kingdom
Tue 03 12:15
MTE4
Meet the Expert 4: Investigation and management of TSHoma
Investigation and management of TSHoma
Cambridge, United Kingdom
Tue 03
Ipsen Satellite: Treatment of pituitary patients: What are the clinical and patients’ needs?
Thyrotropinomas (TSHomas) – do symptoms correlate with disease activity?
Cambridge, United Kingdom
Gordon Hager
Bethesda, USA
Mon 02 18:30
PL3
Plenary Lecture 3: Society for Endocrinology Transatlantic Medal Lecture
An integrated view of nuclear receptor/chromatin interactions
Bethesda, USA
Geoffrey Hammond
Vancouver, Canada
Wed 04 16:15
PL9
Plenary Lecture 9: Society for Endocrinology International Medal Lecture
Controlling the freedom of steroids in health and disease
Vancouver, Canada
Neil Hanley
Wed 04 10:15
APW1.3
Applied Physiology Workshop 1: Evolving model systems for complex tissues
Cell replacement and regeneration of beta cells as novel therapy for diabetes
Kate Hardy
Mon 02 15:30
S5.1
Symposium 5: Premature ovarian insufficiency
Determinants of ovarian follicle reserve: implications for the ageing ovary
Nick Harvey
Mon 02 10:30
S1.1
Symposium 1: Endocrinology meets the environment
Later life consequences of maternal vitamin D deficiency - MAVIDOS Study
Dr Jonathan Hazlehurst
Birmingham, United Kingdom
Tue 03 14:15
OC2.1
Oral Communications 2: Translational pathophysiology and therapeutics
Dual 5-alpha reductase inhibition promotes hepatic lipid accumulation in man as a result of changes to lipid metabolism in adipose tissue and the liver
Birmingham, United Kingdom
Eef Hogervorst
Mon 02 16:00
S5.2
Symposium 5: Premature ovarian insufficiency
Neurological and psychological effects of premature ovarian insufficiency
Anthony Hollenberg
Boston, USA
Tue 03 09:30
PL5
Plenary Lecture 5: British Thyroid Association Pitt-Rivers Lecture
New insights into thyroid hormone action
Boston, USA
Natalie Homer
Edinburgh, UK
Mon 02 12:35
FUT1.3
Futures 1: Branching out with endocrinology
The secret life of a core facilities manager
Edinburgh, UK
Riekelt Houtkooper
Amsterdam, The Netherlands
Mon 02 11:00
S3.2
Symposium 3: Fanning the flames of mitochondrial function
Mitochondrial protein homeostasis in the control of metabolism and aging
Amsterdam, The Netherlands
Dr Sasha Howard
London, UK
Mon 02 15:45
OC1.2
Oral Communications 1:Early Career Prize Session
Mutations in IGSF10 cause self-limited delayed puberty, via disturbance of GnRH neuronal migration
London, UK
Sasha Howard
London, UK
Wed 04 12:30
OC6.3
Oral communications 6: Advances in reproduction and signalling
Mutations in HS6ST1 are causal in self-limited delayed puberty, as well as idiopathic hypogonadotropic hypogonadism
London, UK
Waraporn Imruetaicharoenchoke
Wed 04 12:45
OC5.4
Oral communications 5: Thyroid and parathyroid
A novel modulator of cellular invasion and metastasis in endocrine cancer
Adel Ismail
Wed 04 13:12
SE1.5
Senior Endocrinologists Session
Understanding the biochemistry underpinning hypoglycaemia of the Insulin Autoimmune Syndrome (IAS) is paramount for diagnosis and management
Dr Louise Izatt
London , UK
Tue 03 11:00
N1.2
Nurse Session 1: Multiple Endocrine Neoplasia
Genetics and MEN
London , UK
Chioma Izzi-Engbeaya
Tue 03 17:15
OC4.5
Oral Communications 4: Diabetes and cardiometabolic complications
Glucagon Increases Energy Expenditure Independently of Brown Adipose Tissue Activation in Humans
Frederic Jaisser
Paris, France
Wed 04 11:00
PL8
Plenary Lecture 8: Society for Endocrinology European Medal Lecture
Repositioning of the mineralocorticoid receptor antagonists: pathophysiological basis and therapeutic issues 
Paris, France
Jon Johnston
Mon 02 15:30
S4.1
Symposium 4: It's all in the timing: rhythms underlying endocrine systems
Sleep: what endocrinologists should know about the body clock
Alasdair Jubb
Wed 04 13:15
OC6.6
Oral communications 6: Advances in reproduction and signalling
Glucocorticoids induce rapid and persistent chromatin remodelling at a glucocorticoid receptor bound locus in macrophages
Professor Partha Kar
Portsmouth, UK
Mon 02 12:15
FUT2.1
Futures 2: Overcoming the consultancy hurdle
Perspective of a next generation consultant
Portsmouth, UK
Dr Niki Karavitaki
Birmingham, UK
Mon 02
Pfizer Satellite: Treatment resistance in Acromegaly
Challenges in acromegaly - resistance to somatostatin analogues
Birmingham, UK
Alice Kay
Mon 02 11:37
SK1.4
Skills 1: Working with the media
When hormones hit the headlines
Stephen Kershaw
Tue 03 16:30
OC3.2
Oral Communications 3: Steroids and adrenal
Glucocorticoids stabilise the microtubule network to inhibit cell migration
Alexei Kharitonenkov
Bloomington, USA
Tue 03 14:45
S7.2
Symposium 7: The rise and rise of the FGFs in endocrinology
FGF21: Starvation hormone to clinical drug?
Bloomington, USA
Parisut Kimkool
Mon 02 20:20
FUT3.3
Futures 3: Why endocrinology and diabetes?
An Endocrinology Club in your medical school - from concept to reality
Professor Márta Korbonits
London, United Kingdom
Mon 02
Pfizer Satellite: Treatment resistance in Acromegaly
Managing treatment resistance in Fimilial Isolated Pituitary Adenomas
London, United Kingdom
Olympia Koulouri
Wed 04 12:15
OC5.2
Oral communications 5: Thyroid and parathyroid
A novel, missense, mutation (P81R) in the thyrotropin-releasing hormone receptor gene in congenital central hypothyroidism
Graham Leese
Wed 04 13:15
OC5.6
Oral communications 5: Thyroid and parathyroid
Safety review of liothyronine use: a 20 year observational follow up study
Dr Kate Lines
Oxford, UK
Tue 03 15:30
OC2.6
Oral Communications 2: Translational pathophysiology and therapeutics
Treatment with the epigenetic modifying compound JQ1+ can significantly reduce the proliferation of pancreatic neuroendocrine tumours in a mouse model of multiple endocrine neoplasia type 1 (MEN1)
Oxford, UK
Phil Lowry
Wed 04 12:00
SE1.1
Senior Endocrinologists Session
The new tachykinin, endokinin: its role in emesis, sialorrhea and smoking in pregnancy
Kenneth MacDonald
Mon 02 11:14
SK1.3
Skills 1: Working with the media
What journalists need from scientists
Tracy Mak
Tue 03 17:00
OC4.4
Oral Communications 4: Diabetes and cardiometabolic complications
Hyperinsulinaemia due to inhibition of 5α-reductases is ameliorated by liver-selective glucocorticoid receptor antagonism in diet-induced obesity
Alison McNeilly
Tue 03 16:15
OC4.1
Oral Communications 4: Diabetes and cardiometabolic complications
Acute intense exercise restores defective counter-regulation in Type 1 Diabetes through a process of dis-habituation
Eirini Meimaridou
Mon 02 16:00
OC1.3
Oral Communications 1:Early Career Prize Session
RNA-sequencing of mouse adrenals reveals the pathways perturbed by loss of nicotinamide nucleotide transhydrogenase
Florian Merkle
Wed 04 09:15
APW1.1
Applied Physiology Workshop 1: Evolving model systems for complex tissues
Modelling human diseases with stem cell derived hypothalamic neurones
Karen Miller
Boston, USA
Tue 03 16:15
S9.1
Symposium 9: The endocrinology of the thin
Endocrine dysfunction in anorexia nervosa
Boston, USA
Dr Carla Moran
Dublin, Ireland
Tue 03 16:45
CMW3.2
Clinical Management Workshop 3: Biological therapies - cause and cure of endocrine diseases
Endocrine sequelae of biological therapies
Dublin, Ireland
Professor Annice Mukherjee
Coventry , UK
Wed 04 09:45
CMW4.3
Clinical Management Workshop 4: How do I do it? (II)
How far do I investigate chronic fatigue?
Coventry , UK
Dr Helen Murphy
Cambridge, UK
Tue 03 14:15
S8.1
Symposium 8: Fine-tuning of metabolic state for optimal pregnancy outcome
Revolutionising Type 1 diabetes metabolic control in pregnancy
Cambridge, UK
Dr Robert Murray
Leeds, UK
Mon 02
Otsuka Satellite: Which way now in hyponatraemia? Reviewing new consensus guidelines
Interactive case studies
Leeds, UK
Wed 04
Shire Satellite: Understanding adrenal insufficiency (AI): from disease burden to treatment evaluation
Assessing disease burden in AI: data from the real world
Leeds, UK
Professor John Newell-Price
Sheffield, UK
Mon 02 20:00
FUT3.1
Futures 3: Why endocrinology and diabetes?
What endocrinology did for me – from a consultant’s perspective
Sheffield, UK
Society Office
Mon 02 10:52
SK1.2
Skills 1: Working with the media
Working with press officers to promote your research
Professor Michael O'Reilly
Dublin, Ireland
Mon 02 16:15
OC1.4
Oral Communications 1:Early Career Prize Session
Adipose tissue-specific androgen generation fuels an adverse metabolic phenotype in patients with polycystic ovary syndrome
Dublin, Ireland
Sam O'Toole
Tue 03 14:30
OC2.2
Oral Communications 2: Translational pathophysiology and therapeutics
Adrenal vein catecholamine levels and ratios: reference intervals derived from patients with primary aldosteronism
Dr Bryn Owen
London, UK
Mon 02 17:30
ECP1.1
Early Career Prize Lectures
Basic Science - The Physiology and Pharmacology of the Fasting-Induced Hormone, FGF21
London, UK
Victoria Parker
Tue 03 11:30
SK2.5
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
Making social media work for promoting and recruiting science
Munro Peacock
Indianapolis, USA
Tue 03 15:15
S7.3
Symposium 7: The rise and rise of the FGFs in endocrinology
Targeting FGF23 in bone disease
Indianapolis, USA
Dr Nicola Peel
Sheffield, UK
Mon 02 15:30
CMW1.1
Clinical Management Workshop 1: How do I do it? (I)
How do I report and interpret a DXA scan?
Sheffield, UK
Robin Peeters
Rotterdam, The Netherlands
Tue 03 11:00
S6.2
Symposium 6: Clinical implications of thyroid genomics
Genetic underpinning of thyroid function in health and disease
Rotterdam, The Netherlands
Professor Petros Perros
United Kingdom
Mon 02 16:30
CMW1.5
Clinical Management Workshop 1: How do I do it? (I)
How do I prevent thyroid eye disease after radioiodine?
United Kingdom
Wed 04 14:45
MTE8
Meet the Expert 8: Updated thyroid cancer guidelines
Updated thyroid cancer guidelines
United Kingdom
Nelly Pitteloud
Lausanne, Switzerland
Tue 03 14:15
S7.1
Symposium 7: The rise and rise of the FGFs in endocrinology
FGFs and hypogonadism
Lausanne, Switzerland
Marysia Placzek
Sheffield, UK
Wed 04 09:45
APW1.2
Applied Physiology Workshop 1: Evolving model systems for complex tissues
Regeneration in the hypothalamus
Sheffield, UK
Randall Platt
Boston, USA
Tue 03 12:15
MTE5
Meet the Expert 5: What every endocrine researcher should know about genome editing
What every endocrine researcher should know about genome editing
Boston, USA
Vikki Poole
Wed 04 13:00
OC6.5
Oral communications 6: Advances in reproduction and signalling
Pituitary tumor transforming gene binding factor (PBF): a novel modulator of iodide uptake and target for Src phosphorylation in breast cancer
John Pooley
Mon 02 16:30
OC1.5
Oral Communications 1:Early Career Prize Session
Interaction of the MR and GR in the Nucleus and at DNA
Julia Prague
Mon 02 20:10
FUT3.2
Futures 3: Why endocrinology and diabetes?
Let me tell you how it is – from a trainee’s perspective
Marcus Quinkler
Berlin, Germany
Wed 04
Shire Satellite: Understanding adrenal insufficiency (AI): from disease burden to treatment evaluation
Treatment and management of AI: insights from a German cohort
Berlin, Germany
Dr Richard Quinton
Newcastle, UK
Mon 02 10:30
SK1.1
Skills 1: Working with the media
Why should we engage with the media?
Newcastle, UK
Dr Martin Read
Birmingham, UK
Wed 04 12:00
OC5.1
Oral communications 5: Thyroid and parathyroid
Functional consequences of germline mutations in a novel non-RET medullary thyroid cancer susceptibility gene
Birmingham, UK
Dr Aled Rees
Cardiff, United Kingdom
Mon 02
Otsuka Satellite: Which way now in hyponatraemia? Reviewing new consensus guidelines
Current thinking in the management of hyponatraemia and SIADH
Cardiff, United Kingdom
Rebecca Reynolds
Edinburgh, United Kingdom
Tue 03 14:45
S8.2
Symposium 8: Fine-tuning of metabolic state for optimal pregnancy outcome
Pregnancy and obesity
Edinburgh, United Kingdom
Rachel Richardson
Tue 03 17:30
OC4.6
Oral Communications 4: Diabetes and cardiometabolic complications
Cardiac fibrosis and the balance between glucocorticoid and mineralocorticoid receptor signalling
Victoria Salem
London, UK
Tue 03 16:30
OC4.2
Oral Communications 4: Diabetes and cardiometabolic complications
Thermal imaging as a novel non-invasive method to measure human brown adipose tissue activity in humans
London, UK
Mario Salvi
Alessandria, Itay
Tue 03 16:15
CMW3.1
Clinical Management Workshop 3: Biological therapies - cause and cure of endocrine diseases
The thyroid and rituximab
Alessandria, Itay
Nadia Schoenmakers
Cambridge, UK
Wed 04 13:00
OC5.5
Oral communications 5: Thyroid and parathyroid
Investigating the genetic architecture of gland-in-situ congenital hypothyroidism by comprehensive screening of eight known causative genes
Cambridge, UK
Peter Selby
Wed 04 09:30
CMW4.2
Clinical Management Workshop 4: How do I do it? (II)
How do I manage refractory hypocalcaemia
Professor Robert Semple
Edinburgh, UK
Mon 02 14:15
PL1
Plenary Lecture 1: Society for Endocrinology Starling Medal Lecture
Hyperactive PI-3-Kinase signalling without hormone excess: between cancer and endocrinology
Edinburgh, UK
Cedric Shackleton
Oakland, USA
Wed 04 12:36
SE1.3
Senior Endocrinologists Session
Steroid mass spectrometry: a 50 year history
Oakland, USA
Matthew Simmonds
Tue 03 10:30
SK2.1
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
Engaging with the public: conveying the wonders of science
Karolina Skorupskaite
Wed 04 12:00
OC6.1
Oral communications 6: Advances in reproduction and signalling
Neurokinin B receptor antagonist limits kisspeptin-10 induced LH secretion in women
Rowena Speak
Tue 03 15:00
OC2.4
Oral Communications 2: Translational pathophysiology and therapeutics
Development of a long-acting growth hormone antagonist for the treatment of acromegaly
Francesca Spiga
Bristol, United Kingdom
Mon 02 16:00
S4.2
Symposium 4: It's all in the timing: rhythms underlying endocrine systems
Rhythms of adrenal glucocorticoid secretion
Bristol, United Kingdom
Helen Spoudeas
Wed 04 10:15
CMW4.5
Clinical Management Workshop 4: How do I do it? (II)
How do I manage hormone replacement in teenagers/young adults with learning difficulties?
Professor Paul Stewart
Leeds, UK
Mon 02 12:25
FUT2.2
Futures 2: Overcoming the consultancy hurdle
Perspective of an established consultant
Leeds, UK
Angela Taylor
Tue 03 14:45
OC2.3
Oral Communications 2: Translational pathophysiology and therapeutics
Further advances in diagnosis of adrenal cancer: a high-throughput urinary steroid profiling method using liquid chromatography tandem mass spectrometry (LC-MS/MS)
Raj Thakker
Oxford, United Kingdom
Tue 03 09:00
PL4
Plenary Lecture 4: Society for Endocrinology Dale Medal Lecture
Calcium regulation: from rhinos to molecules
Oxford, United Kingdom
Tue 03 11:15
SK2.4
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
Making your impact statement pack a punch
Oxford, United Kingdom
Christina Thirlwell
Tue 03 17:15
CMW3.3
Clinical Management Workshop 3: Biological therapies - cause and cure of endocrine diseases
Biological agents in pancreatic neuroendocrine tumours
Christopher Thompson
Dublin, Republic of Ireland
Wed 04 14:45
MTE10
Meet the Expert 10: Diagnosis and management of SIADH
Diagnosis and management of SIADH
Dublin, Republic of Ireland
Ana Tiganescu
Tue 03 16:45
OC3.3
Oral Communications 3: Steroids and adrenal
11β-HSD1-mediated decrease in COX-2 expression is abrogated by hypoxia in human dermal fibroblasts
Paul Tissier
Mon 02 16:30
S4.3
Symposium 4: It's all in the timing: rhythms underlying endocrine systems
Dynamics In Hypothalamic-Pituitary Function Over Multiple Time-scales
Professor Jeremy Tomlinson
Oxford, UK
Mon 02 16:15
CMW1.4
Clinical Management Workshop 1: How do I do it? (I)
How do I manage adrenal suppression?
Oxford, UK
Andrew Toogood
Wed 04 10:30
CMW4.6
Clinical Management Workshop 4: How do I do it? (II)
How do I manage men who have used anabolic steroids?
Doug Turnball
Mon 02 11:30
S3.3
Symposium 3: Fanning the flames of mitochondrial function
Mitochondrial disease: problems and solutions
Dr Helen Turner
Oxford, UK
Tue 03 15:15
N2.3
Nurse Session 2: Nurse-led clinics
Medicolegal aspects of endocrine nursing
Oxford, UK
Bijay Vaidya
Exeter
Tue 03 15:15
S8.3
Symposium 8: Fine-tuning of metabolic state for optimal pregnancy outcome
Autoimmune thyroid disease before and during pregnancy
Exeter
Mark Vanderpump
Mon 02 11:00
S1.2
Symposium 1: Endocrinology meets the environment
Iodine deficiency
Katharina Wang
Munich, Germany
Mon 02 16:45
OC1.6
Oral Communications 1:Early Career Prize Session
Urine steroid metabolomics as a diagnostic tool in primary aldosteronism
Munich, Germany
Nick Wareham
Wed 04 15:45
AYI1
A year in...Type 2 diabetes
A year in...Type 2 diabetes
Tony Weetman
Mon 02 19:20
D1.2
Debate: This house believes that patients with hypothyroidism should be offered combination treatment with T3 and T4 if they do not respond to Levothyroxine
AGAINST
Wilmar Wiersinga
Amsterdam, The Netherlands
Mon 02 11:30
S1.3
Symposium 1: Endocrinology meets the environment
Environmental influences on autoimmunity
Amsterdam, The Netherlands
Professor John Wilding
Liverpool, United Kingdom
Wed 04 09:15
S10.1
Symposium 10: Blood and guts: how the intestine transduces nutritional cues to endocrine signals
Incretin hormones as regulators of appetite: from concept to clinical use
Liverpool, United Kingdom
Graham Williams
Mon 02 12:15
MTE2
Meet the Expert 2: T4 vs T4/T3 – evidence vs expectations?
T4 vs T4/T3 – evidence vs expectations?
Karen Winer
Bethesda, USA
Tue 03 12:15
MTE6
Meet the Expert 6: Frontiers in the management of hypoparathyroidism
Frontiers in the management of hypoparathyroidism
Bethesda, USA
Kym Winter
Tue 03 11:30
N1.3
Nurse Session 1: Multiple Endocrine Neoplasia
Psychological support of the MEN patient
Morag Young
Clayton, Australia
Wed 04 12:30
S12.2
Symposium 12: Corticosteroids - getting to the heart of the matter
Selective targeting of the mineralocorticoid receptors (MR) and cardiovascular disease
Clayton, Australia
Faiez Zannad
Nancy, France
Wed 04 13:00
S12.3
Symposium 12: Corticosteroids - getting to the heart of the matter
MR antagonists - lessons from clinical trials
Nancy, France
P1
FHH3-associated AP2σ Mutations Impair MAPK Signalling Pathways
Angela Rogers, Caroline Gorvin, Michael Whyte, Rajesh Thakker
P2
Exploring the N-ethyl-N-nitrosourea (ENU) mutagenesis DNA archive for mutations in NFIX to derive mouse models for Marshall-Smith syndrome (MSS)
Kreepa Kooblall, Mark Stevenson, Sian Piret, Paul Potter, Roger Cox, Steve Brown, Raoul Hennekam, Rajesh Thakker
P3
Reduction in daily hydrocortisone dose in adrenal insufficiency improves significantly bone mineral density – results from a 2-years prospective trial
Julia Schulz, Kathrin Koetz, Manfred Ventz, Sven Diederich, Marcus Quinkler
P4
Mutations in G-protein Subunit α<sub>q</sub> (GNAQ) are not a Cause of Familial Hypocalciuric Hypercalcaemia (FHH)
Manish Modi, Treena Cranston, Angela Rogers, Sarah Howles, Caroline Gorvin, Rajesh Thakker
P5
Soy protein with isoflavones reduce bone turnover markers in women during their early menopause - A randomised double blind parallel study
Thozhukat Sathyapalan, Mo Aye, Eric S Kilpatrick, Alan S Rigby, William D Fraser, Natalie J Thatcher, Stephen L Atkin
P6
Increased circulating sclerostin levels in type 2 diabetic rats are not associated with changes in bone sclerostin production
Marie Pereira, Stephanie Gohin, Nina Lund, Anne Hvid, Peter Smitham, Michael Oddy, Ines Reichert, Chantal Chenu
P7
Differential effects of Parathyroid Hormone on key regulators of osteoblast mineralisation
Dean Houston, Katherine Myers, Vicky MacRae, Jose Luis Millan, Katherine Staines, Colin Farquharson
P8
Type 2 diabetes, bone mineral density and disc height
Rachel Agius, Stephen Fava
P9
The decreased plasma levels of sclerostin but not Dickkopf-1 are associated with increased risk of osteoporotic fracture and lower bone mineral density in Korean postmenopausal women
Yejee Lim, Jung-Min Koh, Beom-Jun Kim, Moo-Il Kang, Seung Hun Lee, Ki Hyun Baek, Yumie Rhee, Yong-Ki Min, Deog-Yoon Kim, Chong Hwa Kim
P10
A mutation in the Calcium Sensing Receptor (previously known to cause Neonatal Severe Hyperparathyroidism in the homozygote state) causing Familial Benign Hypocalciuric Hypercalcaemia in the heterozygote.
John Hinnie, Andrew Gallagher, Angela Collie
P11
The Effect of Oestradiol Circadian Rhythm on the Bone Mineral Density of Adult Males
Sajini Wijetilleka, Muhammad Khan, Aung Mon, Frank Joseph, William Fraser, Jiten Vora
P12
Familial Hypocalciuric Hypercalcaemia due to AP2S1 mutation in a patient with failed Parathyroidectomies - a case report
Eswari Chinnasamy, Paul Hurley, Katie Snape, Gul Bano
P13
Pre-operative localization of parathyroid adenomas in patients with primary hyperparathyroidism (PHPT): Can a single modality of imaging be adequate?
Hafsa Imran, Paul Wilson, Rebecca Sinha, George Varughese, Ullal Nayak, Lakshminarayanan Varadhan
P14
A rare presentation of primary hyperparathyroidism.
Vidhya R Jahagirdar, Neil J Gittoes
P15
Lessons learnt after failed parathyroidectomy
Antonia Ugur, Rajiv Dave, Daniel Ashmore, Olivia Pereira, Deedar Ali
P16
Melorrheostosis: A rare cause of bone pain and limb deformity
Vinit Kirankumar Shah, Neil Gittoes
P17
Denosumab improves bone density in a female patient with severe anorexia nervosa
Andrew Jamieson, Anthony Pelosi, Georgina Weatherdon
P18
Improved Glycaemia following Parathyroidectomy for Primary Hyperparathyroidism
Rajni Mahto, Umar Raja, Deborah Markham
P19
A comparison of plasma copeptin and AVP responses during saline infusion studies.
Christopher Boot, Louise Hughes, Stephen Turner, Stephen Ball, Dermot Neely
P20
Use of ADH antagonists results in lower hospital resource usage: a retrospective cohort study
Paul Grant, Clare Jamookeeah, Penny Dhanjal, Gethin Griffith
P21
Genetic hypocalcaemia: a case of 22q deletion syndrome
Heather Watson, Alexander McGeoch, Waiel A Bashari, Mohammad I Butt, Samson O Oyibo, Satyanarayana V Sagi
P22
Effect of cortisol assay bias on the overnight dexamethasone suppression test: implications for the investigation of Cushing's syndrome
Rachel Brixey-McCann, Sarah Tennant, John Geen, Annie Armston, Julian H Barth, Brian Keevil, Aled Rees, Carol Evans
P23
Using SDHB immunostaining in characterising Pheochromocytoma and Paraganglioma
Anand Velusamy, Louise Izatt, Moonim Mufaddal, Barbara McGowan, Jonathan Hubbard, Rupert Obholzer, Paul Carroll
P24
Serum cortisol: What is your laboratory measuring?
James Hawley, Laura Owen, Phillip Monaghan, Annie Armston, Carrie Chadwick, Brian Keevil
P25
Vasopressin-2 receptor antagonists: potent but potentially dangerous drugs for the treatment of severe hyponatraemia secondary to Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Vikki Tilliridou, Waiel A Bashari, Samson O Oyibo
P26
Lactic Dehydrogenase, a biochemical marker to predict foetal outcome in pregnancies complicated by Intrauterine Growth Restriction  
AMRIT GUPTA, SHYAM PYARI JAISWAR, JYOTI ARORA
P27
Turn off the taps.
Sophie Jones, Mariam Alexander, Christopher Hilton, Sanjeev Mehta
P28
Where are the endocrinologists?
Chloe Broughton, Shaza Ahmed, Beas Bhattacharya
P29
The Epidemiology of Hyper-prolactinaemia
Enrique Soto-Pedre, Paul Newey, John Bevan, Graham Leese
P30
Audit of management of patients with hypomagnesaemia in district general hospital
K. Tofeec, L. Pichaipillai, T. Bani, A. JOSTEL, Y. Demssie
P31
Single-centre audit of the diagnostic performance of plasma metanephrines with seated sampling for the diagnosis of phaeochromocytoma/paraganglioma.
Christopher Boot, Barry Toole, Sarah Johnson, Stephen Ball, Dermot Neely
P32
An unusual presentation of osmotic demyelination syndrome
Vinit Kirankumar Shah, Jayadave Shakher
P33
Management of inpatient hypokalaemia: a District General Hospital (DGH) experience
Lucia Chen, Siva Sivappriyan
P34
Alkaline Phosphatase may predict tumour volume in patients with parathyroid adenoma
Hamid Mani, Franceska Lorford, Thrasos Macriyiannis, Miles Levy
P35
Biochemical Evaluation of Adrenal Incidentalomas Referred to Endocrine Surgery in a Large Teaching Hospital
Andrew Davison, Charlotte Hill, Nicki Russell, Alison Waghorn, Susannah Shore
P36
Inhibiting more than the proton pump
Chloe Broughton, Shaza Ahmed, Beas Bhattacharya
P37
Asymptomatic hypokalaemia in an identical twin
Bnar Talabani, Preethi Nalla, Mohammad Adlan, Lakdasa Premawardhana
P38
Severe hyponatraemia in an inpatient setting - a role for the Endocrinologist?
Eveleigh Nicholson, Jana Bujanova, Iain Cranston
P39
Are we doing to many Short Synecthan Test
mohammad rahman, kofi Obuobie, onyebuchi Okosieme, Nadia El Farhan, Khaliq hamdan
P40
A case of B Cell Lymphoma of brain presenting as Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Suresha Muniyappa, Zulfiquar Zaida, Abdul Abdul
P41
Audit of the diagnosis and management of primary hyperparathyroidism        
Pei Chia Eng, Langstaff Lorna, Kaplan Felicity, Mochloulis George, Winocour Peter
P42
Novel treatment of refractory hypercalcaemia -A serendipitous discovery
Isuri Kurera, Jenny Bosworth, Frances Coyle, Jennifer Tringham, Mehjabeen Beebeejaun, Emma Bingham
P43
What is the prevalence of severe post-operative hypocalcaemia in patients who have undergone parathyroid surgery or a total thyroidectomy at the RVI, Newcastle? Does vitamin D play a role?
Anna Pawlak, Richard Quinton, Peter Truran, Thomas Lennard, Richard Bliss, Andrew Heed
P44
Urgent requirement for better patient selection for Short Synacthen Tests: results from a clinical audit.
Bernard Freudenthal, Daniel Beder, Arla Ogilvie
P45
Using Skype follow-up consultations for patients with thyroid disease
Catherine Gouveia, Shanti Vijayaraghavan, Susan Gelding
P46
Review in a specialist Turner clinic improves management
Caroline Packer, Christopher Jones, Paul Clift, Andrew Toogood
P47
A rare incidental cause of Cushing’s syndrome
Khaled Tofeec, Angela Paisley
P48
Partial response to sunitinib therapy in a metastatic dopamine-secreting paraganglioma.
Melanie Nana, Aled Rees
P49
Outcome of patients with Adrenal Incidentalomas: an analysis of  145 patients from a single centre
Emily Austin, Asad Rahim, Lisa Shepherd, Andrew Bates
P50
Early post-operative aldosterone concentration can be used to assess outcome from adrenalectomy in aldosterone producing adenoma
Irfan Baig, Barbara McGowan, Jake Powrie, Jonathan Hubbard, Paul Carroll
P51
Saccular Internal Carotid Artery Aneurysm Masquerading as Pituitary Macroadenoma
Louise Goldsmith, Stella Williams, Nabile Mohsin, Upendram Srinivas-Shankar
P52
Impact of a multidisciplinary diabetic foot clinic on patient outcomes
Lowri Phillips, Louise Osborne
P53
Out-of-hours cover for diabetes and endocrinology: a single UK tertiary centre experience
Sam O'Toole, Nigel Glynn, Cathy Gouveia, Raquel Sanchez Windt, Craig Stiles, Rasheeta Sivapackianathan, Scott Akker, Maralyn Druce, Mona Waterhouse, William Drake
P54
TB or not TB: that is the question
Catriona Farrell, Colin Perry
P55
A case of Polyglandular Autoimmune Disease associated with Common Variable Immunodeficiency
Ishrat Khan, Mirena Noyvirt, Aicha Bouraoui, Penny Owen, Helen Lane
P56
Phaeochromocytoma in pregnancy: good luck and judgement lead to a successful outcome
Mie Mie Tisdale, Neil Burgess, Alastair McKelvey, Debbie O'Hare, Francesca Swords
P57
Audit on Continuous Subcutaneous Insulin Infusion (CSII- Insulin Pump) Therapy:
Giulia Argentesi, Seifeledin Yahia, Anastasios Gazis
P58
Vitamin D deficiency in haemodialysis patients; treatment with colecalciferol.
Sharon Huish, Simon Fletcher, Janet Dunn, Martin Hewison, Rosemary Bland
P59
DIPNECH: under-recognised and a diagnostic challenge
Veneranda Lorelei Salazar, Ronan O'Driscoll, Annice Mukherjee
P60
Sodium-Glucose Co-Transporter 2 Inhibitor associated Normoglycemic Ketoacidosis
Shane Bobart, Benjamin Gleason, Jonathan Schroeder, Nydia Martinez, Keith Norris, Sandra Williams
P61
A novel management of Gitelman's syndrome
Suchitra Raj, Ahkallya Kuganolipava, Abiola Fatimilehin, James Clark, Benjamin Field, Sunil Zachariah
P62
Nothing to "sea" here: turning a blind eye to hyponatraemia
Chloe Broughton, Shaza Ahmed, Beas Bhattacharya
P63
A case to remember
mohammad Rahman, Kofi Obuobie, Tom Hickin, Khaliq Hamdan
P64
Resistant Hypocalcaemia Secondary to Denosumab: Two Case Reports.
Caroline Clay, Jan Hoong Ho, Maia Severn, Kalpana Kaushal, Simon Howell
P65
Multiple endocrine paraneoplastic syndromes in a patient with lung malignancy.
Alex Lewis, Isha Malik, Kelly Cheer, Cuong Dang
P66
National Audit of Transition in Endocrinology: Joint between Society for Endocrinology and the British Society of Paediatric Endocrinology & Diabetes
Helena Gleeson, Avril Mason, Colin Perry, Guftar Sheikh, Lorraine Albon, Antonia Brooke, Sailesh Sankar, Rohana Wright, Paul Dimitri
P67
IgG4 related hypophysitis: A novel candidate to the hypophysitis spectrum
Shemin S Vyas, Simon Page, Seifeldin Yahia, Peter Lanyon
P68
Management of Thyroid Disease in Pregnancy: Experience from an Antenatal Thyroid Clinic
Micha Thomas, Zaki Hassan-Smith, Andrew Bates, Asad Rahim
P69
Endometrial Hyperplasia in Transmen - to scan or not to scan?
Leighton Seal, Iffy Middleton, James Barrett
P70
Steroid responsive hypoglycaemia in a patient with spindle cell sarcoma
Emily Tafadzwa Mudenha, Andrew Okpe, Devaka Fernando
P71
Does the usual time of rising influence the stimulated cortisol response?
Anh Tran, Steve Hyer, Rashim Salota, Nikhil Johri, Andrew Rodin
P72
A woman with thyroid metastases twenty one years after renal carcinoma excision, with biphasic thyroid dysfunction on Sunitinib
Preethi Nalla, Bnar Talabani, Mohamed Adlan, Lakdasa Premawardhana
P73
Immobilisation hypercalcaemia in two intensive care patients
Jodie Sabin, Sharman Harris, Pierre Peyrasse, Ian Johnson, Ginette Jones, Anthony Wilton